Chemical structure of the monoamine and indole neurotransmitter serotonin. Chemical structure of the monoamine and catecholamine neurotransmitter dopamine. A<unk>  (SDRI) is a type of drug which acts as a reuptake<unk>  of the monoamine neurotransmitters serotonin and dopamine by blocking the actions of the serotonin transporter (SERT) and dopamine transporter (DAT), respectively. This in turn leads to increased extracellular concentrations of serotonin and dopamine, and, therefore, an increase in serotonergic and dopaminergic neurotransmission. A closely related type of drug is a serotonin–dopamine releasing agent (SDRA).
Serotonin–dopamine reuptake inhibitor
Serotonin–norepinephrine reuptake inhibitor
Norepinephrine reuptake inhibitor
Glycine reuptake inhibitor
Dopamine reuptake inhibitor
Serotonin–norepinephrine–dopamine reuptake inhibitor
Monoamine reuptake inhibitor
Acetylcholinesterase inhibitor